Earnings

NextCure Q2 EPS $(2.80) Misses $(1.94) Estimate

Aug 6, 2026 · 05:47 PM ET· updated 1h ago

NextCure (NASDAQ:NXTC) reported quarterly losses of $(2.80) per share which missed the analyst consensus estimate of $(1.94) by 45.08 percent. This is a 75.2 percent increase over losses of $(11.29) per share from the

Why It Matters

NextCure lost more money per share than experts predicted—their losses were bigger than expected. When a company loses more money than people thought, it means the business might be struggling harder than everyone realized.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

NXTC5.27

+0.02 (+0.38%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.